t.zielinski
Submits third-party assay reports on material purchased directly. Based in Odense.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.95%
n=6
Suppliers covered
5
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042504 | IGF-1 LR3 | Homopeptide | HOMO-2607-P5131 | Janoshik | 2026-Q3 | 99.08 | 6.26 | 105.0 | Buyer-sourced | 0 | PASS |
| AX-2026-043260 | Tirzepatide | CPC | CPC-2605-P1014 | VendorInvestigate | 2026-Q2 | 97.58 | 4.60 | 96.2 | Laboratory-retained | 0 | PASS |
| AX-2026-041597 | Ipamorelin | QSC | QSC-2602-W7583 | PeptideMeter | 2026-Q1 | 99.93 | 6.48 | 101.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019391 | CJC-1295 (no DAC) | HYB | HYB-2504-N7248 | Medutest | 2025-Q3 | 99.48 | 4.27 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004813 | Retatrutide | HJ | HJ-2411-M5834 | PeptideMeter | 2024-Q4 | 98.70 | 6.18 | 101.3 | Buyer-sourced | 0 | PASS |
| AX-2024-005177 | Semax | CPC | CPC-2309-M9933 | Janoshik | 2024-Q1 | 98.82 | 5.79 | 93.7 | Supplier-supplied | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| CPC | 2 | n<3 |
| Homopeptide | 1 | n<3 |
| QSC | 1 | n<3 |
| HYB | 1 | n<3 |
| HJ | 1 | n<3 |